Please login to the form below

Not currently logged in
Email:
Password:

benign prostatic hyperplasia

This page shows the latest benign prostatic hyperplasia news and features for those working in and with pharma, biotech and healthcare.

CHMP backs Sanofi’s all-oral sleeping sickness drug

CHMP backs Sanofi’s all-oral sleeping sickness drug

Italy’s Recordati also got a positive opinion for Silodosin Recordati (siloosin) a generic of its own Urorec drug used to treat benign prostatic hyperplasia (BPH).

Latest news

More from news
Approximately 1 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • Interview: Giovanni Recordati Interview: Giovanni Recordati

    The company also has long expertise in urology. “We are currently rolling out a new drug for the treatment of benign prostatic hyperplasia and will soon be starting the last phase

  • Call to action for BPH

    Campaign:ProState of the Nation. Timescale:February to October 2009. ProState of the Nation is an evidence-based report, bringing the issues of under-management and under-treatment of Benign Prostatic ... Benign Prostatic Hyperplasia (BPH) is a condition

  • Interview: Jorge Gallardo, Almirall Interview: Jorge Gallardo, Almirall

    The year's sales evolution has benefited from the launches of new products Silodyx (for benign prostatic hyperplasia, licence from Recordati)  and Conbriza  (for osteoporosis, in co-promotion with Pfizer) in

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics